Anti-titin antibody is associated with more frequent hospitalization to manage thymoma-associated myasthenia gravis
Background and purposeAnti-titin antibodies are antistriational antibodies associated with thymoma-associated myasthenia gravis (MG). We evaluated whether the patients with anti-titin antibody are more frequently hospitalized to manage thymoma-associated MG than those patients without anti-titin ant...
Main Authors: | Ki Hoon Kim, Seung Woo Kim, Jinhyuk Cho, Hye Yoon Chung, Ha Young Shin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2022.978997/full |
Similar Items
-
Immunological and Structural Characterization of Titin Main Immunogenic Region; I110 Domain Is the Target of Titin Antibodies in Myasthenia Gravis
by: Christos Stergiou, et al.
Published: (2023-02-01) -
Ocular myasthenia gravis and thymoma
by: Victor Alegre-Ituarte, et al.
Published: (2022-09-01) -
Neuropsychiatric symptoms in patients with thymoma-associated and non-thymoma myasthenia gravis
by: Carla Freeman, et al.
Published: (2014-07-01) -
Thymoma with Myasthenia Gravis in Adolescent
by: Prasad K Shetty,, et al.
Published: (2011-01-01) -
Thymoma-associated myasthenia gravis coexisting with myotonic dystrophy: a case report
by: Michiyo Miyawaki, et al.
Published: (2021-07-01)